Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SK

Sergej Kiprijanov — 7 Patents

OMOmeros: 5 patents #24 of 108Top 25%
AAAffitech Research As: 2 patents #5 of 12Top 45%
Oslo, NO: #208 of 2,623 inventorsTop 8%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Sergej Kiprijanov has been granted 7 US patents while listed as an inventor at Omeros. The first was granted in 2014 and the most recent in March 2023. Sergej Kiprijanov ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Sergej Kiprijanov in Oslo, NO.

Patents per Year

Patents granted per year, 2014 to 2023Bar chart with a peak of 2 patents in 2014.peak 22014: 2 patents20142015: 1 patents20152016: 1 patents20162018: 1 patents20182020: 1 patents20202023: 1 patents2023

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11613589 Compositions for inhibiting MASP-2 dependent complement activation Thomas Dudler, Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie +2 more 2023-03-28 $9,118,000
10683367 Compositions for inhibiting MASP-2 dependent complement activation Thomas Dudler, Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie +2 more 2020-06-16 $16,561,000
10047165 Compositions for inhibiting MASP-2 dependent complement activation Thomas Dudler, Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie +2 more 2018-08-14 $20,662,000
9475885 Compositions for inhibiting MASP-2 dependent complement activation Thomas Dudler, Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie +2 more 2016-10-25 $5,074,000
9011860 Compositions for inhibiting MASP-2 dependent complement activation Thomas Dudler, Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie +2 more 2015-04-21 $16,588,000
8748107 Isolated antibodies which bind to CXC chemokine receptor 4 Anita Kavlie 2014-06-10
8637017 Anti-EpCAM antibodies Lavinia Diana Cicortas Gunnarsson, Didrik Paus, Jenny KARLSSON, Remko Albert Griep 2014-01-28